New incident report
Incident Report Number: 2010-4285
Registrant Reference Number: 4349098
Registrant Name (Full Legal Name no abbreviations): Sure-Gro Inc.
Address: 150 Savannah Oaks Dr.
City: Brantford
Prov / State: Ontario
Country: Canada
Postal Code: N3V 1E7
Domestic Animal
Country: CANADA
Prov / State: BRITISH COLUMBIA
PMRA Registration No. 19228 PMRA Submission No. EPA Registration No.
Product Name: Wilson Earwig Destroyer
Unknown
Unknown
Animal's Owner
Dog / Chien
Maggie
1
Female
10
40
lbs
Oral
>15 min <=2 hrs / >15 min <=2 h
Unknown / Inconnu
System
>2 hrs <=8 hrs / > 2 h < = 8 h
Yes
Unknown
Fully Recovered / Complètement rétabli
Accidental ingestion/Ingestion accident.
(eg. description of the frequency and severity of the symptoms
The owner was out of the house from approx 1530 to 1730. While she was gone, the dog ingested an unknown amount of the product. There was nothing else the dog may have gotten into. The owner was advised that this products is a carbamate insecticide of moderate toxicity. Typically muscarinic signs are first seen and include salivation, lactimation, urination and defecation, along with miosis, vomiting and bradycardia. Nicotinic signs may include twitching, weakness and tremors. CNS signs of hyperactivity and seizures may be seen with high doses. The owner was advised to take the animal into their local DVM. On Jan 27during a routine follow up call the owner had advised that she did take Maggine directly into the DVM. By the time she arrived at the clinic, the dog was vomiting and having seizures. The DVM administered AC and Atropine. The signs ended within about 12 hours. The dog is now back at home, doing very well.
Minor
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified.